Moffitt Presentation at AACR 2026

ED17 - Implementation Science Approaches to Advancing Equitable Cancer Prevention and Control | Presentation: An introduction to implementation science using lung cancer screening in HIV care
Education Session
Jessica Yasmine Islam
4:46-5:06 p.m.
Room 28 - Upper Level Convention Center

ED42 - Cancer Metabolism as a Therapeutic Frontier | Presentation: Metabolic vulnerabilities in cancer
Educational Session
Gina DeNicola
12:31-12:51 p.m.
Ballroom 6B - Upper Level Convention Center

DC01 - Where Expedited Pathways, Innovation, Safety, and Patient Access Collide: A KRAS Case Study
Educational Session
Ignacio Garrido-Laguna
12:40-12:55 p.m.
Room 1 - Upper Level Convention Center

ED19 - Identification and Management of Reduced Penetrance High-risk Cancer Gene Variants | Presentation: Functional approaches to identify reduced penetrance pathogenic variants (RPPVs)
Educational Session
Alvaro Monteiro
2:30-4:00 p.m.
Room 15 - Mezzanine Level Convention Center

ED53 - Cancer Systems Biology, Ecology, and Evolution | Presentation: Phase I trials in cancer: From board to bench to bedside and back again
Educational Session
Sandy Anderson
2:51-3:11 p.m.
Room 28 - Upper Level Convention Center

MW07 - Bridging the Gap: Multilevel Strategies to Expand Access to Cancer Clinical Trials | Presentation: Advancing clinical trials: Working through outreach, navigation and digitally enabled referral and recruitment strategies (ACT WONDER2S)
Methods Workshop
Susan Vadaparampil
12:45-12:57 p.m.
Room 31 - Upper Level Convention Center

DC09 - Approaches to Drug Development for Rare Malignancies
Major Symposium
Eric Padron
1:15-1:30 p.m.
Room 1 - Upper Level Convention Center

9 / 9 - ShinyEvents: Harmonizing real-world longitudinal data for clinical insights and survival analytics
Alyssa Obermaye

657 / 5 - The era of NAMS, incorporating tumor heterogeneity and immune context into human-relevant patient avatar cancer models
W. Gregory Sawyer

908 / 21 - An intersectional analysis of physical and mental health-related quality of life among LGBTQ+ patients with cancer
Rolando Trejos

888 / 1 - Impact of neighborhood disadvantage, travel distance, and travel time on clinical outcomes of multiple myeloma patients treated with idecabtagene vicleucel
Alicia Richards

1251 / 25 - Real-world evaluation of multimodal AI: Foundation model-driven multimodal AI for GBM, NSCLC, and PDAC
Aakash Gireesh Tripathi

2080 / 10 - Aged-induced increases in IL-11 leads to immune escape and PD-1 resistance in melanoma through myeloid cell polarization
Michael Emmons

2239 / 14 - The transcobalamin receptor, CD320, is a therapeutic target for metastatic triple negative breast cancer
Joanne Tejero

2123 / 21 - A high resolution spatial transcriptomic atlas of the bone marrow microenvironment pre and post prostate cancer seeding
Haley du Bois

DC05 - Strengthening the Oncology Trial Ecosystem Through Operational and Regulatory Innovation
Major Symposium
Jason Lebsack
10:30-11:45 a.m.
Room 1 - Upper Level Convention Center

3937 / 12 - Investigation of inherited genetic variation for predictors of immune mediated colitis following immune checkpoint inhibitor (ICI) therapy of patients (pts) with melanoma
Ahmad Tarhini

2749 / 13 - Towards a foundation model for treatment-related adverse events in cancer immunotherapy
Bin Baek

2715 / 8 - A comprehensive single-cell atlas of head and neck squamous cell carcinoma defines malignant cell states and enables deconvolution of legacy bulk transcriptomic cohorts
Yuantuan Shen

LB245 / 20 - Collagen remodeling promotes a GPCR-mediated mechanosensory immune checkpoint in ADGRG1+ CD8+ T cells and serves as a spatial biomarker of response to immunotherapy
Late Breaking Poster
Sonal Srivastava

3734 / 6 - Early-onset low-grade adverse events as predictive biomarkers in advanced NSCL: A multi-treatment cohort analysis
Dung-Tsa Chen

3203 / 13 - Deciphering gene regulatory network and spatial heterogeneity underlying cutaneous T cell lymphoma large cell transformation
Xiaofei Song

3620 / 6 - The human virome and its association with clinical benefit of immune checkpoint inhibitor therapy among patients with advanced non-small cell lung cancer
Anna Coghill

2781 / 12 - Investigating feature selection strategies with habitat-based radiomics for oropharyngeal cancer
Oya Altinok

4187 / 14 - scOncoNet: Dual-graph attention network for program-aware in-silico gene perturbation in single-cell cancer data
Tingyi Li

4687 / 7 - The BRCT domain is a modular platform for signal transduction in the DNA damage response
Thales Nepomuceno

6009 / 10 - Mitochondrial glutathione reductase as a redox vulnerability in KEAP1/NRF2-mutant non-small cell lung cancer
Yun Huang

6257 / 19 - Associations of area level deprivation with survival outcomes among patients with newly diagnosed colorectal cancer considered across the lifespan
Jessica Burns

6129 / 20 - Microenvironmentally-driven dynamic deposition of histone H3.3 controls entry and exit from dormancy in disseminated cancer cells
Stanislav Drapela

5476 / 12 - GLEAM: Democratizing high-quality machine learning for cancer research
Paulo Cilas Morais Lyra Junior

6286 / 16 - Functional assessment of RECQL4 missense variants identified in RECQL4genetic disorder-associated osteosarcomas
Brian Rodemoyer

5442 / 9 - Identifying cell-cell interactions across spatial scales in spatial transcriptomics
Alex Soupir

6632 / 1 - Trends in treatment and survival among patients with glioblastoma in the United States, 2000 to 2020: A population-based SEER analysis
Jianan Chen

LB402 / 2 - Homologous recombination deficiency sensitizes breast cancer to therapeutic targeting of the ectonucleotidase ENPP1
Late Breaking Research
Brian Ruffell
2:50-3:05 p.m.
Room 5 - Upper Level Convention Center

6768 - Selective ULK1/2 inhibitors enhance KRAS pathway blockade and uncover stress-adaptive programs
S. Bayle
2:50-3:05 p.m.
Ballroom 20 AB - Upper Level Convention Center

6814 - Tumor-stroma spatial context of T cell infiltration and exhaustion as determinants of ovarian cancer survival in Black women
B. M. Reid
3:20-3:35p.m.
Room 15 - Mezzanine Level Convention Center

6824 - Old age uncovers FGFR-dependent metabolic dependencies in TNBC lung metastasis with therapeutic potential
S. Drapela
3:35-3:50 p.m.
Ballroom 6A - Upper Level Convention Center

6727 - Enhancing lung cancer risk prediction with longitudinal fusion of LDCT data
H. Ajami
3:50-4:05 p.m.
Ballroom 20 CD - Upper Level Convention Center

6842 / 13 - ctDNA precedes imaging: A predictive model for real-time treatment adaptation in HPV-associated anal squamous cell carcinoma
Phebe M.A Havor

7444 / 28 - Tetraspanin-driven metabolic plasticity and chemoresistance in disseminated breast cancer cells
Alexia Brunel

7559 / 7 - Implementation of an interactive clinical trials education and decision tool for Florida cancer patients at an NCI Center
Margaret Byrne

7399 / 16 - Eosinophils promote an immunosuppressive bone marrow microenvironment in multiple myeloma
Haley du Bois

7592 / 12 - Machine learning enables accurate prediction of patient outcomes for immune checkpoint blockade using real-world clinical data
Alyssa Pybus

7589 / 9 - On the road to early detection: A survey of barriers and facilitators to community participation in mobile lung cancer screening
Matthew Schabath